Anlotinib for Recurrent or Metastatic Primary Malignant Bone Tumor: A Multicenter, Single-Arm Trial

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/DC9DA778.svg?ark=w1%2F20261004%2FDC9DA778&value=id)](https://nobleid.org/work/w1/20261004/DC9DA778)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →